Pfizer (PFE) Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Pfizer (PFE) Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys

Sarepta Therapeutics gains as Pfizer failure removes overhang

June 13, 2024 10:57 AM EDT

Sarepta Therapeutics (NASDAQ: SRPT) stock rose over 3% Thursday after Pfizer (NYSE: PFE) announced disappointing results from its Phase 3 CIFFERO trial of its gene therapy fodadistrogene movaparvovec after the close on Wednesday.

The trial failed to meet... More